NAC (N-Acetyl Cysteine): Clinical Evidence & Substantiation Summary
What Is NAC (N-Acetyl Cysteine)?
N-Acetyl Cysteine (NAC) is a bioavailable form of the amino acid L-cysteine and a precursor to glutathione, the body's master antioxidant. It has a long clinical history — originally used as a mucolytic agent — and is now widely studied for its antioxidant, detoxification, and respiratory support properties.
Mechanism of action: NAC replenishes intracellular glutathione (GSH) by providing cysteine, the rate-limiting amino acid in GSH synthesis. It directly scavenges free radicals, modulates the inflammatory NF-κB pathway, breaks disulphide bonds in mucus glycoproteins (mucolytic effect), and supports phase II liver detoxification enzymes.
Clinical Evidence Summary
Below are 5 key clinical studies on NAC (N-Acetyl Cysteine). Nutra Comp analyses 53+ studies in its full clinical evidence report.
Efficacy of oral N-acetylcysteine in the treatment of acetaminophen overdose: analysis of the national multicenter study
Population: 11,195 patients
Key finding: NAC remains the gold standard for acetaminophen-induced hepatotoxicity, demonstrating significant hepatoprotective effects.
N-acetylcysteine as an adjunct to antidepressants: A systematic review and meta-analysis
Population: 5 RCTs, 574 participants
Key finding: NAC as adjunct therapy significantly improved depressive symptoms vs. placebo (SMD -0.37, p=0.02).
Oral N-acetylcysteine supplementation and exercise performance: a systematic review
Population: 12 studies
Key finding: NAC supplementation showed some benefit in delaying fatigue during prolonged exercise, potentially via reduced oxidative stress and glutathione replenishment.
N-Acetylcysteine in COPD: A Review of Its Potential as Mucolytic and Antioxidant
Population: Multiple RCTs
Key finding: NAC at 600–1,200 mg/day significantly reduced exacerbation frequency in COPD patients and improved respiratory function markers.
Effect of N-acetylcysteine on oxidative stress markers: a systematic review
Population: 18 studies
Key finding: NAC supplementation significantly increased blood glutathione levels and reduced markers of oxidative stress (MDA, 8-OHdG) across multiple populations.
Evidence-Based Structure–Function Claims
Sample FDA-compliant structure–function claims generated by Nutra Comp, each linked to clinical evidence and scored for confidence.
Get the full substantiation report for NAC (N-Acetyl Cysteine)
Includes all 53+ clinical studies analysed, complete claims library, and a ready-to-file substantiation memo.
Join Waitlist for Full AccessRelated Ingredients
Key Terms
Frequently Asked Questions
Is NAC FDA approved?
NAC has a complex regulatory history. It is FDA-approved as a prescription drug (Mucomyst) for acetaminophen overdose. Its status as a dietary supplement ingredient has been debated by the FDA, but it remains widely available as a supplement. Brands should monitor FDA guidance on NAC's supplement status.
What are the most studied benefits of NAC?
NAC is best studied for glutathione replenishment (antioxidant support), respiratory health (mucolytic properties), liver support (hepatoprotection), and emerging evidence for mood support. Its role in acetaminophen toxicity treatment is the gold-standard medical use.
What dosage of NAC is used in clinical studies?
Most supplement-focused studies use 600–1,200 mg/day, often in divided doses. Some research uses up to 1,800 mg/day. Higher doses are typically used in clinical/hospital settings for acute indications.
Stop Spending Weeks on Substantiation
Nutra Comp generates full clinical evidence reports, FDA-compliant structure–function claims, and substantiation memos in minutes — not months.
Join the Waitlist